期刊文献+

p16基因表达与胃癌临床生物学特征及预后的研究 被引量:2

Expression of p16 gene in Gastric Cancer and Its Correlation to Biologic Prognosis
下载PDF
导出
摘要 目的:检测与分析p16基因表达产物在胃癌组织中的表达。探讨其与胃癌术后复发、转移及生存率的关系。方法:应用免疫组织化学方法检测84例胃癌标本中p16蛋白的表达。结果:84例中p16表达阳性率44.05%,转移淋巴结表达阳性率37.50%,明显低于正常组织及胃良性息肉。p16表达与组织学类型无关,与肿瘤浸润深度、临床分期及淋巴结转移有关。随访中发现,阴性表达者死亡率高、中位生存期短,转移复发率均高于阳性表达者(P<0.01)。结论:p16蛋白异常表达在胃癌的发生发展过程中起重要作用。其可能成为临床评估肿瘤生物学行为及判断预后的标志之一。 Objective: To detect and analyse the expression of p16 gene in gastric cancer tissues and to explore its correlation with the postoperative recurrence, metastasis and survival rate of gastric cancer. Method: The expression of p16 in 84 gastric cancer patients were studied by immunohistochemistry and follow up survey. Results: The positive rate of p16 gene in 84 specimens of gastric cancer tissues was 44.05% and its lymph node metastatic rate was 37,05% which was lower than that in normal tissues (P<0.01). It was not correlated with its histologic type. However, but it was correlated with the lymph node metastasis, survival rate, and it invaded the various layers of stomach. Conclusion: Abnormal expression of p16 plays an important role in development of gastric cancer. p16 gene can be used to evaluate the tumor biologic behavior and the prognosis of disease.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2001年第8期569-571,共3页 Chinese Journal of Clinical Oncology
基金 本文课题受全军科研基金资助 (编号 95A44)
关键词 胃癌 P16基因 免疫组织化学 生物学特征 预后 Gastric cancer p16 immunohistochemistry
  • 相关文献

参考文献2

  • 1Cheng J Q,Cancer Res,1994年,35547页
  • 2Cairns P,Nature,1994年,256卷,415页

同被引文献13

  • 1Fromovitz FB,viola MV,Chao S,et al. Ras. p21 expression in the prognosion of breast cancer[J]. Hum Pathol, 1987, 18 (12):1268-1275.
  • 2Tsujie M, Yamamoto H, Tomita N et al. Expression of tumor suppressor gene APE1 (INK) products in primary gastric cancer[J]. Oncology, 2000,58(2) : 126-136.
  • 3谭立新,林华,章平,等,APEl蛋白中胃癌组织中的难点及临床意义[J].中国肿瘤临床与康复,2001,9(3):38-39.
  • 4Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliieration[J]. Int J Cancer, 1983, 31 (1):13-20.
  • 5Zalewski B, KemonaA. Evaluation of proliferating markers Ki-67, PCNA in gastric cancers [J]. Rocz Akad Med Bialymst, 2004,49 (Suppl 1 ) : 64-66.
  • 6Ma YL, Peng JY, Zhang P, et al. Immunohistochemical analysis revealed CD34 and Ki67 protein expression as significant prognostic factors in colorectal cancer [J]. Med Oncol,2010,27(2) :304-309.
  • 7Nakajima M, Sawada H, Yamads Y, et al. The prognostic significance of amplification and overexpression of c-met and cerbt2 in human gastric cancinoma[J]. Cancer, 1999, 85 (9) : 1894-1902.
  • 8崔小伟,张庆瑜.HER2/neu在胃癌中的研究进展[J].国际消化病杂志,2008,28(4):309-311. 被引量:6
  • 9胃癌病理分型和诊断标准的建议[J].中华病理学杂志,2010,39(4):266-269. 被引量:123
  • 10施达仁.胃癌中HER2的检测[J].中华病理学杂志,2010,39(7):501-502. 被引量:9

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部